𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection

✍ Scribed by W. Krause; T. Mager; G. Kühne; T. Duka; B. Voet

Publisher
Springer
Year
1991
Tongue
English
Weight
446 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis

The plasma concentration of lisuride and prolactin have been measured in twelve healthy male volunteers after IV, IM or SC injection of 25 micrograms lisuride hydrogen maleate as an aqueous solution. After IV administration the plasma lisuride fell in two phases with half-lives of 14 min and 1.5 h. Total clearance was 13 ml.min-1.kg-1. After IM and SC injection the plasma concentrations peaked at 12 to 15 min and the profiles were similar to that found after IV administration. The systemic availabilities were 90% and 94%, respectively. Prolactin concentrations were reduced by a maximum of 60% relative to the normal circadian rhythm after all three routes of administration. The treatments were well tolerated, the only adverse reactions reported by some of the volunteers being mild, transient dizziness, tiredness, and nausea.

📜 SIMILAR VOLUMES

Pharmacokinetics of moxisylyte in health
Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and intracavernous administration
✍ Pierre Costa; Francoise Bressolle; Brigitte Sarrazin; Jacqueline Mosser; Marc Ga 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

The concentration-time profiles of metabolites of moxisylyte, an alpha-adrenergic receptor blocking agent, in the plasma of 12 healthy volunteers were investigated after intravenous (iv) and intracavernous (ic) administrations. The study was conducted in open, randomized, Latin Squares. Plasma level

Pharmacokinetics and safety of binodenos
Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers
✍ Richard J. Barrett; Michael J. Lamson; James Johnson; William B. Smith 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 181 KB

## Background: Binodenoson, a highly selective agonist of the adenosine a 2a receptor, is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging. this study was designed to assess the single-dose pharmacokinetics, safety, and tolera

Pharmacokinetics of the antidepressant l
Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers
✍ Dr. G. Kaiser; R. Ackermann; W. Dieterle; I. W. Reimann; P. R. Bieck 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

To investigate the pharmacokinetics and the disposition of levoprotiline after i.v. and p.0. administration and to assess the absolute bioavailability, 12 healthy volunteers (1 1 women, 1 man) were given a 10 min i.v. infusion of 15 mg and a p.0. dose of 75 mg in a two-way crossover study. Blood and

The pharmacokinetics of oral and intrave
The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers
✍ A. F. Clarke; D. B. Jack; M. J. Kendall; S. R. Smith 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

The pharmacokinetics of prenalterol in healthy young volunteers after i.v. and oral dosing has been studied. There is evidence of non-linearity following the i.v. dosing. Evidence of dose-dependent pharmacokinetics following i.v. dosing has been obtained. The sustained-release formulation is very ef